News & Media

    08/20/2015
    Raymond A. Dionne D.D.S., Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board 
    05/08/2014
    Gary A. Peltz, M.D. Joins Charleston Laboratories, Inc Scientific Advisory Board 
    05/02/2014
    Charleston Laboratories, Inc. Announces Publication of Abstract for CL-108 Phase 3 Study at APS 2014 
    03/22/2013
    Charleston Laboratories, Inc submitted a request with the U.S. Food and Drug Administration (FDA) for a Pre-Investigational New Drug (Pre-IND) meeting regarding the development of CL-H1T. 
    01/28/2013
    Robert H. Dworkin, Ph.D Joins Charleston Laboratories, Inc Scientific Advisory Board 
    01/07/2013
    31st Annual J.P. Morgan Healthcare Conference 
    12/01/2012
    Charleston Laboratories, Inc. Appoints Ryan Baker Executive Vice President and Chief Operating Officer 
    09/03/2012
    Charleston Laboratories, Inc. Appoints Bill Kozarek Ph.D Vice President of Product Development 
    01/09/2012
    30th Annual J.P. Morgan Healthcare Conference 
    05/18/2009
    BIO International Convention 2009 
    02/02/2009
    Charleston Completes Preliminary Research on Nausea-Prone Questionnaire (NPQ) 
    01/12/2009
    Charleston Labs begins Bioequivalence Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CL-108 
    01/12/2009
    27th Annual J.P. Morgan Healthcare Conference 
    01/09/2009
    Charleston Sucessfully Completes Series A Private Placement 
    10/03/2008
    Charleston Laboratories, Inc. Investigational New Drug CL-108 “Safe to Proceed Testing in Man.” 
    01/07/2008
    26th Annual J.P. Morgan Healthcare Conference 
    08/01/2007
    Charleston Laboratories, Inc. Appoints Bernard Schachtel, M.D. Chief Medical Officer 
    08/01/2007
    Charleston Laboratories, Inc. Appoints John F. Ameling V.P of Regulatory Affairs